Table 2.

Patient-related factors of MAVs as identified via univariate and multiple linear regression analyses

Variable	Univariate			Multiple
	β	95% CI	P value	β	t value	P value
Age (20–64, 65–74, ≥ 75 years)	0.020	− 0.004, 0.044	0.10
Duration of diabetes (< 10, 10–19, ≥ 20 years)	0.007	− 0.019, 0.032	0.59
BMI (< 25, ≥ 25 kg/m2)	− 0.030	− 0.072, 0.011	0.15
HbA1C (%)	− 0.010	− 0.021, 0.001	0.07
Complications of diabetes
Nephropathy	0.019	− 0.024, 0.061	0.38
Retinopathy	0.002	− 0.040, 0.044	0.92
Macrovascular disease	0.044	− 0.003, 0.092	0.07
Number of chronic diseases	0.017	0.007, 0.026	< 0.001	0.017	3.585	< 0.001
Number of OHAs	− 0.021	− 0.041, 0.0001	0.05	− 0.021	− 2.129	0.04
Insulin therapy (%)	0.029	− 0.012, 0.070	0.17
Number of non-hypoglycemic agents	0.009	0.004, 0.014	< 0.001
Adverse events	− 0.006	− 0.048, 0.037	0.80
Adverse events related hypoglycemic agents
Hypoglycemia	− 0.006	− 0.057, 0.045	0.81
Others	− 0.024	− 0.069, 0.021	0.29
Family history of diabetes	− 0.005	− 0.048, 0.038	0.82
Current drinking	− 0.043	− 0.100, 0.013	0.13
Dietary supplement	− 0.033	− 0.089, 0.023	0.24
Employed	− 0.049	− 0.091, − 0.007	0.02
Living alone	0.035	− 0.027, 0.098	0.26
Marital status	− 0.019	− 0.063, 0.026	0.40

Measurements were carried out using univariate and multiple liner regression analyses

Adjusted R² = 0.13, P < 0.001

β standard regression coefficient, BMI body mass index, CI confidence interval, MAVs medication adherence values, OHAs oral hypoglycemic agents